查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455671

微生物组治疗市场，按产品类型、按应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Microbiome Therapeutics Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年微生物组疗法市场规模为1.0245亿美元，2024年至2032年复合CAGR为36.78%。

微生物组疗法市场-市场动态

微生物组研究的进展推动市场需求

大多数正在开发的治疗药物都处于早期阶段，通常是 I 期和 II 期。关于胃肠道 (GI) 适应症，23 种药物中有超过 13 种正在研究中，其中大多数集中于溃疡性结肠炎。例如，2021 年，Seres Therapeutics, Inc. 介绍了其针对 SER-109 的 3 期 ECOSPOR III 研究资料，SER-109 是一种针对复发性艰难梭菌感染的口服疗法，预计将于2023 年上半年推出。值得注意的是，与安慰剂相比，SER-109 与抗菌素抗药性基因的减少有关。微生物组研究的进步预计将有助于发现感染和其他疾病的改进治疗方法，从而提高医疗保健效果。为了促进基于微生物组的治疗的采用，公司正在降低产品成本，并将尖端医疗服务扩展到更广泛的人群。此外，一些管理机构正在调整其方法。因此，这为市场供应商提供了利润丰厚的成长机会，以提高其市场份额。

微生物组疗法市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 36.78% 左右的CAGR成长

根据产品类型细分，FMT 预计将在 2023 年呈现最大市场份额

根据应用细分，艰难梭菌是 2023 年的主导类型

按地区划分，北美是 2023 年的主要收入来源

微生物组疗法市场細項分析：

全球微生物组治疗市场根据产品类型、应用和区域进行细分。

根据产品类型，市场分为两类：FMT 和微生物组药物。 2023年，粪便微生物疗法（FMT）成为微生物组治疗市场的主导力量。这种优势主要归因于其在治疗艰难梭菌感染中的广泛应用。此外，越来越关注旨在探索 FMT 替代治疗应用的研究和开发，再加上胶囊剂进入市场，预计将推动其成长。例如，2021 年 2 月，OpenBiome 宣布在粪便微生物群治疗製剂中引入针对 SARS-COV-2 的新直接检测，旨在提高计划患者紧急使用 FMT 的可用性，同时降低感染传播风险。

根据应用市场分为五类：艰难梭菌、克隆氏症、发炎性肠道疾病、糖尿病和其他。与艰难梭菌感染（CDI 或艰难梭菌）相关的应用领域预计将在2023 年保持市场主导地位。该领域的扩张归因于越来越多地采用粪便微生物移植(FMT) 来治疗艰难梭菌感染。根据伯明翰大学 2020 年进行的一项研究，FMT 被广泛接受用于治疗艰难梭菌感染患者。此外，与抗生素相比，FMT 在治疗艰难梭菌方面表现出更大的功效，特别是在復发的情况下。

微生物组治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

微生物组疗法市场-竞争格局：

微生物组治疗市场的公司采用各种策略来保持竞争力，包括投资研发以探索新的治疗应用、提高产品的可及性和可负担性、促进与研究机构和医疗保健提供者的合作，以及利用技术进步来提高产品的功效和安全性。这些策略旨在推动创新，扩大市场覆盖范围，并最终改善基于微生物组的治疗领域的患者治疗效果。

最近的发展：

2021 年 12 月，Kaleido Biosciences 宣布与杨森合作，探索微生物组代谢疗法在预防儿童期出现的免疫、特异性和代谢疾病的功效。

目录

第 1 章：微生物组疗法市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的微生物组疗法市场片段
    • 微生物组疗法市场片段（按应用）
    • 按国家/地区分類的微生物组疗法市场片段
    • 按地区分類的微生物组疗法市场片段
  • 竞争洞察

第 3 章：微生物组疗法主要市场趋势

  • 微生物组疗法市场驱动因素
    • 市场驱动因素的影响分析
  • 微生物组疗法市场限制
    • 市场限制影响分析
  • 微生物组疗法的市场机会
  • 微生物组疗法市场未来趋势

第 4 章：微生物组疗法产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：微生物组治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：微生物组疗法市场格局

  • 微生物组疗法市占率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：微生物组治疗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • FMMT
    • 微生物组药物

第 8 章：微生物组治疗市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 艰难梭菌
    • 克罗恩病
    • 发炎性肠道疾病
    • 糖尿病
    • 其他的

第 9 章：微生物组治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美微生物组疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲微生物组疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区微生物疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲微生物组疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 微生物组疗法中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 微生物组治疗产业

  • 竞争仪表板
  • 公司简介
    • OpenBiome
    • Seres Therapeutics Inc.
    • D Pharma plc.
    • Locus Biosciences, Inc.
    • Enterome SA
    • Finch Therapeutics Group, Inc.
    • Intralytix, Inc.
    • Microbiotica
    • Second Genome
    • Rebiotix Inc.
    • Vedanta Bioscience, Inc.
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2334

REPORT HIGHLIGHT

Microbiome therapeutics Market size was valued at USD 102.45 Million in 2023, expanding at a CAGR of 36.78% from 2024 to 2032.

Microbiome therapeutics entail the development and application of treatments directed at the human microbiome, which comprises a complex community of microorganisms residing within the human body. These therapeutics are designed to restore, manipulate, or enhance microbial balance within the body, thereby fostering health and addressing various medical conditions. They manifest in different forms, including probiotics (live beneficial bacteria), prebiotics (substances promoting the growth of beneficial bacteria), postbiotics (metabolites produced by beneficial bacteria), and fecal microbiota transplantation (the transfer of fecal matter from a healthy donor to a recipient).

Microbiome therapeutics Market- Market Dynamics

Advancements in microbiome research to propel market demand

The majority of therapeutic agents in development are in the early stages, typically Phase I and Phase II. Regarding gastrointestinal (GI) indications, over 13 drugs out of 23 are under investigation, with the majority focusing on ulcerative colitis. For example, in 2021, Seres Therapeutics, Inc. introduced data from its Phase 3 ECOSPOR III study on SER-109, an oral therapy investigated for recurrent C. difficile infection, with an anticipated launch slated for the first half of 2023. Notably, compared to the placebo, SER-109 is associated with a decrease in antimicrobial resistance genes. Advancements in microbiome research are expected to facilitate the discovery of improved treatments for infections and other diseases, thereby enhancing medical care outcomes. To promote the adoption of microbiome-based treatments, companies are reducing the cost of their products and expanding access to cutting-edge medical care to a broader segment of the population. Additionally, several governing bodies are restructuring their approaches. Consequently, this presents market vendors with lucrative growth opportunities to enhance their market share.

Microbiome therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 36.78% over the forecast period (2024-2032)

Based on Product Type segmentation, FMT was predicted to show maximum market share in the year 2023

Based on Application segmentation, C. difficile was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Microbiome therapeutics Market- Segmentation Analysis:

The Global Microbiome therapeutics Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on Product Type: FMT and Microbiome Drugs. In 2023, Fecal Microbiota Therapy (FMT) emerged as the dominant force in the microbiome therapeutics market. This dominance is primarily ascribed to its extensive utilization in treating C. difficile infection. Additionally, the growing focus on research and development aimed at exploring alternative therapeutic applications of FMT, coupled with the introduction of capsules into the market, is anticipated to propel its growth. For instance, in February 2021, OpenBiome announced the introduction of new direct testing for SARS-COV-2 in fecal microbiota therapy preparations, aiming to enhance FMT availability to scheduled patients for emergency use while mitigating the risk of infection transmission.

The market is divided into five categories based on Application: C. difficile, Crohn's disease, Inflammatory Bowel Disease, Diabetes and Others. The application segment pertaining to Clostridium difficile infection (CDI or C. difficile) is forecasted to maintain dominance in the market in 2023. The expansion of this segment is attributed to the increasing adoption of Fecal Microbiota Transplants (FMT) for treating C. difficile infections. According to a 2020 study conducted by the University of Birmingham, FMT is widely accepted for treating patients afflicted with Clostridium difficile infections. Furthermore, FMT demonstrates greater efficacy in treating C. difficile compared to antibiotics, particularly in cases of recurrence.

Microbiome therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Microbiome therapeutics Market- Competitive Landscape:

Companies in the microbiome therapeutics market employ various strategies to stay competitive, including investing in research and development to explore new therapeutic applications, enhancing product accessibility and affordability, fostering collaborations with research institutions and healthcare providers, and leveraging technological advancements to improve product efficacy and safety. These strategies aim to drive innovation, expand market reach, and ultimately improve patient outcomes in the field of microbiome-based therapies.

Recent Developments:

In December 2021, Kaleido Biosciences revealed a partnership with Janssen to explore the efficacy of microbiome metabolic therapies in preventing immune, atopic, and metabolic conditions that emerge in childhood.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICROBIOME THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

OpenBiome

Seres Therapeutics Inc.

4D Pharma plc.

Locus Biosciences, Inc.

Enterome SA

Finch Therapeutics Group, Inc.

Intralytix, Inc.

Microbiotica

Second Genome

Rebiotix Inc.

Vedanta Bioscience, Inc.

Others

GLOBAL MICROBIOME THERAPEUTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • FMT
  • Microbiome Drugs

GLOBAL MICROBIOME THERAPEUTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • C. difficile
  • Crohn's disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others

GLOBAL MICROBIOME THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Microbiome therapeutics Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Microbiome therapeutics Market Snippet by Product Type
    • 2.1.2.Microbiome therapeutics Market Snippet by Application
    • 2.1.3.Microbiome therapeutics Market Snippet by Country
    • 2.1.4.Microbiome therapeutics Market Snippet by Region
  • 2.2.Competitive Insights

3.Microbiome therapeutics Key Market Trends

  • 3.1.Microbiome therapeutics Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Microbiome therapeutics Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Microbiome therapeutics Market Opportunities
  • 3.4.Microbiome therapeutics Market Future Trends

4.Microbiome therapeutics Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Microbiome therapeutics Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Microbiome therapeutics Market Landscape

  • 6.1.Microbiome therapeutics Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Microbiome therapeutics Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.FMT
    • 7.1.3.Microbiome Drugs

8.Microbiome therapeutics Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.C. difficile
    • 8.1.3.Crohn's disease
    • 8.1.4.Inflammatory Bowel Disease
    • 8.1.5.Diabetes
    • 8.1.6.Others

9.Microbiome therapeutics Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Microbiome therapeutics Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Microbiome therapeutics Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Microbiome therapeutics Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Microbiome therapeutics Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Microbiome therapeutics Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Microbiome therapeutics Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.OpenBiome
    • 10.2.2.Seres Therapeutics Inc.
    • 10.2.3.4D Pharma plc.
    • 10.2.4.Locus Biosciences, Inc.
    • 10.2.5.Enterome SA
    • 10.2.6.Finch Therapeutics Group, Inc.
    • 10.2.7.Intralytix, Inc.
    • 10.2.8.Microbiotica
    • 10.2.9.Second Genome
    • 10.2.10.Rebiotix Inc.
    • 10.2.11.Vedanta Bioscience, Inc.
    • 10.2.12.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Microbiome therapeutics Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Microbiome therapeutics Market, by Product Type 2019-2032 (USD Million)
  • TABLE Microbiome therapeutics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Microbiome therapeutics Market, by Application 2019-2032 (USD Million)
  • TABLE Microbiome therapeutics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Microbiome therapeutics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Microbiome therapeutics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Microbiome therapeutics Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Microbiome therapeutics Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Microbiome therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Europe Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Asia Pacific Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Latin America Microbiome therapeutics Market share and leading players, 2023
  • FIGURE Middle East and Africa Microbiome therapeutics Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE Germany Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE India Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE Brazil Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Microbiome therapeutics Market share analysis by country, 2023
  • FIGURE Saudi Arabia Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Microbiome therapeutics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)